Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-12-18

Clinical Trial Update: How Does Antiretroviral Therapy Affect Coronary Atherosclerosis: a Serial CT Study [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating how antiretroviral therapy affects coronary atherosclerosis, monitored by serial CT scans, has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Liverpool | Conditions: Coronary Artery Disease, Hiv | Phase 4 | Status: WITHDRAWN